Definition library · Exact Dx

Cancer-treatment adverse-event grading scale (NCI CTCAE): off by default

CTCAE grades describe adverse events in people receiving cancer treatment, usually in trials; they are not diagnostic criteria, and several grades depend on the laboratory reference range or on clinical descriptors that are not encoded. Using them outside that setting is a local decision for the clinical reviewer.

Current: Off (default) When on, grading entries are shown only as "another published definition gives …" or as values needing clinical judgement; they never raise a "not stated" item.

CDI or coding staff can change this setting and record reviews: switch the demo user.

Prediabetes ranges (ADA Standards of Care 2026) ada2026_prediabetes@1.0 1 Draft · pending review draft — pending clinical and coding review

Status: draft — pending clinical and coding review (draft — requires clinical and coding review)
Condition: Prediabetes
Tier: 1
Use here: default set (prediabetes)
Edition: Standards of Care in Diabetes—2026 (2026)
Second source: none opened · not found: No independent second source was opened.
Contested: yes: Other bodies (for example WHO) are understood to use a different impaired fasting glucose range and not to use an A1C prediabetes range; those texts were not opened, so no other thresholds are recorded. Review item.

American Diabetes Association Professional Practice Committee, 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2026

ada2026_prediabetes@1.0

A1C 5.7–6.4% (39–47 mmol/mol); FPG 100 mg/dL (5.6 mmol/L) to 125 mg/dL (6.9 mmol/L) (IFG); 2-h PG during 75-g OGTT 140 mg/dL (7.8 mmol/L) to 199 mg/dL (11.0 mmol/L) (IGT)

Standards of Care in Diabetes—2026 (2026) · Table 2.2 Criteria defining prediabetes in nonpregnant individuals · source

Review

No review recorded yet.